Literature DB >> 172625

Effect of albuterol and terbutaline, synthetic beta adrenergic stimulants, on the cyclic 3',5'-adenosine monophosphate system in smooth muscle.

Y Vulliemoz, M Verosky, L Triner.   

Abstract

The effect of albuterol and terbutaline on the cyclic 3',5'-adenosine monophosphate (cAMP) system was studied in rat uterus, aorta and myocardium and in dog bronchus, and was compared to that of isoproterenol in order to determine whether the tissue specificity observed in their functional effects is reflected in their effect on the cAMP system. Tissue specimens were either homogenized in Tris buffer for enzyme activity measurements or incubated in Krebs-Ringer-bicarbonate medium with the test drugs. Both albuterol and terbutaline produce an increase in cAMP content in the tissues due to a direct effect on adenylate cyclase. This effect can be potentiated by a phosphodiesterase inhibitor and antagonized by a beta adrenergic blocking compound. The cAMP response to each beta adrenergic agonist differs in the tissues examined: in uterus and aorta where the maximal effects are idenitcal, the ED50 values may reflect differences in affinity which may account for the different cAMP response to the compounds at the lower concentrations. In bronchus and myocardium, both the maximum effect and ED50 values of the compounds are different. Albuterol and terbutaline increases cAMP content in bronchus significantly and have only a small effect on cAMP cont in myocardium, whereas isoproterenol increases cAMP level significantly in both tissues. The results indicate that the tissue specificity of albuterol and terbutaline may have its origin at the level of the cAMP system.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172625

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Blood cells and endothelial barrier function.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Tissue Barriers       Date:  2015-04-03

2.  Combination bronchodilators: antagonism of airway smooth muscle contractions in vitro.

Authors:  C J Hanna; S H Roth
Journal:  Agents Actions       Date:  1979-04

Review 3.  On the action of combination bronchodilators.

Authors:  C J Hanna; P Eyre
Journal:  Agents Actions       Date:  1979-10

4.  Pulmonary alveolar type II cells isolated from rats. Release of phosphatidylcholine in response to beta-adrenergic stimulation.

Authors:  L G Dobbs; R J Mason
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 5.  Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).

Authors:  Karim Makhlouf; Howard L Weiner; Samia J Khoury
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.